Recipharm will pay SEK640m ($75m) for Italian antibiotic filling specialist Mitim in a deal expected to complete later today.
Recipharm has entered into an agreement to acquire Italian CDMO, Mitim adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialised in the filling of injectable beta lactam products. It is located in Brescia close to Recipharm’s existing operations in Northern Italy. The transaction will complete tomorrow, 24th February 2016.
Mitim s.r.l. News Full Screen View
Market Place
Share